The story of how Swiss pharmaceutical company OM Pharma transformed pharmacovigilance literature screening with an automated solution DrugCard.
Client:
Location:
Switzerland
As PV activities scaled, key process limitations became evident
OM Pharma faced growing pharmacovigilance demands that strained traditional manual processes of literature review and the old-school solution:
- Time-consuming literature surveillance, with safety reviewers spending 5 to 10 minutes per article to identify and assess relevant safety information
- Limited scalability makes it increasingly difficult to keep pace with growing volumes of scientific literature across multiple products
- Fragmented workflows require teams to switch between tools for literature review, relevance assessment, and translation
- Resource-intensive operations, where highly qualified PV professionals spent significant time on repetitive screening and administrative activities instead of expert safety evaluation
Optimising Pharmacovigilance Literature screening Workflows with DrugCard
OM Pharma implemented DrugCard’s local and global literature monitoring solution to transform and streamline pharmacovigilance literature screening workflows, enabling:
- Rapid, high-volume screening and classification of 1,550 scientific articles within the review period
- Seamless PubMed integration, ensuring continuous global literature surveillance and improved coverage
- Advanced document viewer designed to accelerate literature review
- Articles categorization and Quality Check functionality
- Report generation and built-in traceability
- Built-in automated translation capabilities enable efficient review of non-English publications without disrupting workflows
Measurable Impact Across Safety, Speed, and Scale
With DrugCard, OM Pharma transformed its pharmacovigilance literature screening workflow:
- Improved identification of safety relevant articles
- Significant efficiency gains with review time reduced to 1 – 5 minutes per article
- Articles automatically translated, removing a major language-related bottleneck
- Scalable operations with a local 36-product project and a global 18-product project managed by a 5-person team and centralised data processing
Ready to Achieve Similar Results?
Stop risking compliance and wasting valuable team hours. Discover how DrugCard can streamline your literature monitoring, expedite the detection of safety signals, and provide your team with complete peace of mind.
Take the next step and experience a personalised demo tailored just for you!
